NODUS ONCOLOGY LIMITED

Active Edinburgh
2 employees website.com
Life sciences and medical technology
N

NODUS ONCOLOGY LIMITED

Founded 6 Apr 2020 Active Edinburgh, Scotland 2 employees website.com
Life sciences and medical technology
Accounts Submitted 2 Dec 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Apr 2026 Next due 19 Apr 2027 11 months remaining
Net assets £1M £1M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £94K £272K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

61 Dublin Street Edinburgh Midlothian EH3 6NL Scotland

Email

info@example.com

Website

www.example.com

Full company profile for NODUS ONCOLOGY LIMITED (SC658917), an active life sciences and medical technology company based in Edinburgh, Scotland. Incorporated 6 Apr 2020. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£889.51k

Decreased by £1.46M (-62%)

Net Assets

£1.40M

Decreased by £1.14M (-45%)

Total Liabilities

£93.71k

Decreased by £272.00k (-74%)

Turnover

N/A

Employees

2

Debt Ratio

6%

Decreased by 7 (-54%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2022Seed
Investor 2Feb 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 68,843 Shares £4.20m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Dec 202316,077£1.80m£111.96
1 Feb 202312,438£1.39m£111.96
1 Feb 202311,246£1.01m£89.57
28 Oct 202229,082£290.82£0.01

Officers

Officers

3 active
Status
Brown, Julia MaryDirectorScottishScotland601 Jul 2022Active
Doak, ScottDirectorBritishScotland6430 Aug 2022Active
Platt, Clare Jane, DrDirectorBritishScotland623 Dec 2024Active

Shareholders

Shareholders (7)

Cumulus Oncology Limited
44.9%
35,890
Cumulus Oncology Limited
22.3%
17,830

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2020
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent

Group Structure

Group Structure

NODUS ONCOLOGY LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Apr 2026Confirmation StatementConfirmation statement made on 2026-04-05 with no updates
13 Apr 2026OfficersChange to director Dr Clare Jane Wareing on 2026-04-13
2 Dec 2025AccountsAnnual accounts made up to 2024-12-31
6 May 2025OfficersTermination of Ian David Waddell as director on 2025-04-30
28 Apr 2025Confirmation StatementConfirmation statement made on 2025-04-05 with no updates
16 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-04-05 with no updates

13 Apr 2026 Officers

Change to director Dr Clare Jane Wareing on 2026-04-13

2 Dec 2025 Accounts

Annual accounts made up to 2024-12-31

6 May 2025 Officers

Termination of Ian David Waddell as director on 2025-04-30

28 Apr 2025 Confirmation Statement

Confirmation statement made on 2025-04-05 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 2026-04-05 with no updates

1 weeks ago on 16 Apr 2026

Change to director Dr Clare Jane Wareing on 2026-04-13

1 weeks ago on 13 Apr 2026

Annual accounts made up to 2024-12-31

4 months ago on 2 Dec 2025

Termination of Ian David Waddell as director on 2025-04-30

11 months ago on 6 May 2025

Confirmation statement made on 2025-04-05 with no updates

12 months ago on 28 Apr 2025